NU 665 WEEK 13: Crisis Management Case Study What important information is missing from the case study? The case study lacks several critical pieces of information necessary for a comprehensive evaluation. The case fails to provide necessary psychiatric details, which include both past medical diagnoses and evaluations of drug treatment and medication adherence. The healthcare […]
NU 665 Final Case Analysis: Part D: The PMHNP Role in Patient Care Part A: Patient Education When working with a 34-year-old patient who faced Major Depressive Disorder and Post-Traumatic Stress Disorder from multiple Adverse Childhood Experiences, I delivered thorough information about her treatment medication. Given her persistent low mood, hypervigilance, intrusive thoughts, and insomnia, […]
NU 665 Final Case Analysis: Part C: Therapy Session Client Name: Zara Age: 36 Ethnic/Cultural Background: Pakistani-American Setting: Community Mental Health Clinic Zara: Hello, Therapist: I am pleased to see you today, Zara. How are you feeling? Zara: To be honest, my inner state exhibits diverse feelings right now. Since the previous session, a sense […]
NU 665: Final Case Analysis: Part A: Cultural Assessment Part A: Cultural Assessment This cultural assessment is based on a composite case of an adult patient with a history of Adverse Childhood Experiences (ACEs) observed in a community mental health setting. The assessment follows Madeleine Leininger’s Culture Care Theory (CCT) to implement culturally appropriate care […]
NU 665: Final Case Analysis Part B Psychiatric Evaluation Part A: Cultural Assessment This cultural assessment is based on a composite case of an adult patient with a history of Adverse Childhood Experiences (ACEs) observed in a community mental health setting. The assessment follows Madeleine Leininger’s Culture Care Theory (CCT) to implement culturally appropriate care […]
NU 665: Current Issues for the PMHNP Texas Suicide Trends and State Initiatives Suicide death rates for Texas in 2022 fell in the range of 11.26 to <16.52 per 100,000 persons, which positions the state in the middle category compared to other states (Stats of the State – Suicide Mortality, n.d.). Although the relatively average […]
Module 2: HCR 561: Discussion 2 In March 2006, a Phase I clinical trial was conducted at Northwick Park Hospital in London to test a drug called TGN1412, developed by the German company TeGenero. The study was sponsored by Parexel, a U.S.-based clinical research organization. The research aimed to test the safety of the immune-boosting […]
HCR 553 Discussion 2 Contract Manufacturing: Controlling for Quality How can the research site determine and ensure that the investigational drug being tested is in compliance with CGMP and meets Quality Guidelines? The research site must check the process, review records, and involve all partners to prove that an investigational drug is ready for use […]
HCR 561 Module 3: Discussion Board 3 Introductory Statement and Position I recommend that the Amazing IRB allow Dr. Tarry’s involvement in the study, while adding some conditions to maintain ethical practices and supervision. While the approach to styling the form is not typical in the United States, the required regulatory parts were included, and […]
HCR 561 Discussion 3: Quality by Design Using Quality by Design (QbD) means taking a planned and systematic approach to ensuring the quality of pharmaceutical products and clinical trials. The ICH E8(R1) guidance emphasizes that using Quality by Design helps plan clinical trials in a way that identifies important factors affecting participant safety, data accuracy, […]
